In a recent study published in the Journal of American Heart Association, researchers assessed whether non-imaging data could be used to identify people with coronary atherosclerosis....
LYON, France — The first oral small molecule anti–proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor appears to be effective in not only lowering low-density lipoprotein...
LYON, France — Bempedoic acid ( Nexletol) is safe for people with obesity and is effective at lowering lipid levels and rates of major cardiovascular events,...
ORLANDO, Fla. — Patients with type 1 and 2 diabetes who delay treatment with recommended statin therapy to address the well-known high risk for cardiovascular (CV)...
Shadmehr Demehri, MD, PhD The statin pitavastatin (Livalo) could potentially inhibit the production of IL-33, which often contributes to the development of cancer via chronic inflammation,...
A new study led by investigators from Mass General Cancer Center, a founding member of the Mass General Brigham healthcare system, reveals that statins-;commonly used cholesterol-lowering...
Starting statin therapy can reduce the 5-year risk of cardiovascular disease (CVD) for patients aged 75 and older without increasing risks for severe adverse effects, according...